Concepedia
Statistics
Publications
6
Citations
206
H-Index
Active since
2009
Affiliations
AstraZeneca (United Kingdom)(Current)
AstraZeneca (United States)
AstraZeneca (Sweden)
AstraZeneca (Germany)
Kate F. Wickson is an author at AstraZeneca (United Kingdom) specializing in drug discovery, pharmacy, and drug design.
Publications per year
2009–2022
Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl-1 Inhibitors
Jeffrey W. Johannes, Stephanie M. Bates, Carl Beigie et al. · ACS Medicinal Chemistry Letters · 2016 · 60 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
Rapid Generation of a High Quality Lead for Transforming Growth Factor-β (TGF-β) Type I Receptor (ALK5)
Frederick W. Goldberg, Richard A. Ward, Steven J. Powell et al. · Journal of Medicinal Chemistry · 2009 · 43 citations · Full text
Exploration of the HIF-1α/p300 interface using peptide and Adhiron phage display technologies
Hannah F. Kyle, Kate F. Wickson, Jonathan Stott et al. · Molecular BioSystems · 2015 · 36 citations · Full text
Medicine, Cancer Biology, Oncology +14
Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors
Caroline Colley, Bojana Popovic, Sudharsan Sridharan et al. · mAbs · 2017 · 35 citations · Full text
Pharmacy, Immunology, Pharmacology +17
Blocking phospholamban with VHH intrabodies enhances contractility and relaxation in heart failure
Erwin De Genst, Kylie S. Foo, Yao Xiao et al. · Nature Communications · 2022 · 19 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +17
1–5 of 6